MedClinic Partners

Medications offered

As listed on the provider’s own site. Whether a product is FDA-approved or compounded is the single most important distinction here — we explain why.

• Compounded GLP-1s supplied to clinicsCompounded · not FDA-approved

What they publish

MedClinic Partners publishes 1 of 12 standard terms. Fields marked “not publicly disclosed” were not stated on the pages we captured, and we have not filled those gaps with assumptions. Compare disclosure across providers

Membership / programme fee

Not a consumer product; no consumer pricing published

Medication cost

Not publicly disclosed on the pages we captured.

Introductory offer

Not publicly disclosed on the pages we captured.

Insurance

Not publicly disclosed on the pages we captured.

HSA / FSA

Not publicly disclosed on the pages we captured.

Consultation process

Not publicly disclosed on the pages we captured.

Eligibility

Not publicly disclosed on the pages we captured.

Lab work

Not publicly disclosed on the pages we captured.

Pharmacy fulfilment

Publishes guidance distinguishing 503A pharmacies from 503B outsourcing facilities and the compliance rules for each.

Shipping

Not publicly disclosed on the pages we captured.

Support services

Not publicly disclosed on the pages we captured.

Cancellation

Not publicly disclosed on the pages we captured.

Refunds

Not publicly disclosed on the pages we captured.

What stands out

• This is the supply and compliance layer behind clinic-branded compounded GLP-1s.
• Its published 503A/503B guidance is a useful primer on a distinction most consumer sites never explain.
• Not purchasable by individuals.

Questions to ask before you pay

These are things we could not settle from published pages, or that we think are easy to misread. Get answers in writing.

• If a clinic offers compounded GLP-1s, ask which supplier and facility type sits behind it.
• 503B outsourcing facilities are FDA-registered and inspected; 503A pharmacies are regulated primarily by state boards.